Comparison 5. Subgroup indication, tapering versus continuation.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
5.1 Relapse (HR)	13		Hazard Ratio (IV, Random, 95% CI)	Subtotals only
5.1.1 No co‐intervention long‐term follow‐up (≥ 24 weeks)	13		Hazard Ratio (IV, Random, 95% CI)	2.97 [2.24, 3.93]
5.1.2 Subgroup Indication ‐ depressive disorder	10		Hazard Ratio (IV, Random, 95% CI)	2.62 [2.01, 3.42]
5.1.3 Subgroup Indication‐ anxiety disorder	3		Hazard Ratio (IV, Random, 95% CI)	7.06 [3.22, 15.52]